These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9108386)

  • 1. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.
    Scaradavou A; Woo B; Woloski BM; Cunningham-Rundles S; Ettinger LJ; Aledort LM; Bussel JB
    Blood; 1997 Apr; 89(8):2689-700. PubMed ID: 9108386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect.
    Bussel JB; Graziano JN; Kimberly RP; Pahwa S; Aledort LM
    Blood; 1991 May; 77(9):1884-93. PubMed ID: 1850307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura.
    Scaradavou A; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):52-7. PubMed ID: 9523749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?
    Bussel JB; Kaufmann CP; Ware RE; Woloski BM
    Am J Hematol; 2001 May; 67(1):27-33. PubMed ID: 11279654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocytopenic purpura: the New York Hospital experience.
    Scaradavou A
    Semin Hematol; 2000 Jan; 37(1 Suppl 1):42-4. PubMed ID: 10676924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
    Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN
    Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V; Carcao M
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM; El-Agnaf M
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intravenous anti-D in patients with refractory and relapsed immune thrombocytopenic purpura.
    Sajid R; Adil SN; Fadoo Z; Sabir S; Khurshid M
    J Pak Med Assoc; 2003 Nov; 53(11):537-9. PubMed ID: 14738260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
    Yetgin S; Aytaç S; Olcay L; Tunç B; Ozbek N; Aydinok Y
    Turk J Pediatr; 2010; 52(2):126-31. PubMed ID: 20560246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
    Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
    J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD; Francischetti MM
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura.
    Aledort LM; Salama A; Kovaleva L; Robak T; Newland AC; Nugent DJ; Brenner B; Zenker O;
    Hematology; 2007 Aug; 12(4):289-95. PubMed ID: 17654054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How we use WinRho in patients with idiopathic thrombocytopenic purpura.
    Stotler BA; Schwartz J
    Transfusion; 2015 Nov; 55(11):2547-50. PubMed ID: 26094894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.